1. Home
  2. NVAX vs NBTB Comparison

NVAX vs NBTB Comparison

Compare NVAX & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • NBTB
  • Stock Information
  • Founded
  • NVAX 1987
  • NBTB 1856
  • Country
  • NVAX United States
  • NBTB United States
  • Employees
  • NVAX N/A
  • NBTB N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • NBTB Major Banks
  • Sector
  • NVAX Health Care
  • NBTB Finance
  • Exchange
  • NVAX Nasdaq
  • NBTB Nasdaq
  • Market Cap
  • NVAX 2.0B
  • NBTB 2.0B
  • IPO Year
  • NVAX 1995
  • NBTB N/A
  • Fundamental
  • Price
  • NVAX $8.47
  • NBTB $50.45
  • Analyst Decision
  • NVAX Buy
  • NBTB Buy
  • Analyst Count
  • NVAX 6
  • NBTB 5
  • Target Price
  • NVAX $17.83
  • NBTB $42.60
  • AVG Volume (30 Days)
  • NVAX 5.8M
  • NBTB 218.1K
  • Earning Date
  • NVAX 11-12-2024
  • NBTB 10-28-2024
  • Dividend Yield
  • NVAX N/A
  • NBTB 2.70%
  • EPS Growth
  • NVAX N/A
  • NBTB 0.14
  • EPS
  • NVAX N/A
  • NBTB 2.85
  • Revenue
  • NVAX $885,193,000.00
  • NBTB $538,802,000.00
  • Revenue This Year
  • NVAX N/A
  • NBTB N/A
  • Revenue Next Year
  • NVAX N/A
  • NBTB $16.98
  • P/E Ratio
  • NVAX N/A
  • NBTB $17.69
  • Revenue Growth
  • NVAX N/A
  • NBTB 10.23
  • 52 Week Low
  • NVAX $3.53
  • NBTB $32.79
  • 52 Week High
  • NVAX $23.86
  • NBTB $51.93
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 41.69
  • NBTB 63.95
  • Support Level
  • NVAX $6.81
  • NBTB $48.59
  • Resistance Level
  • NVAX $10.39
  • NBTB $51.93
  • Average True Range (ATR)
  • NVAX 0.66
  • NBTB 1.47
  • MACD
  • NVAX 0.09
  • NBTB 0.05
  • Stochastic Oscillator
  • NVAX 46.37
  • NBTB 81.64

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. NBT Bank is a full-service community bank offering a full range of retail and commercial banking products and trust and investment services. Loan products include consumer, home equity, mortgage, business banking, and commercial loans. Nearly half of its loan portfolio is in commercial loans. The bank serves individuals, corporations, and municipalities, and operates scores of locations throughout New York, Pennsylvania, Vermont, Massachusetts, New Hampshire, and Maine.

Share on Social Networks: